Fundz

Cencora, Inc. to Acquire American Oncology Network, Inc. in Strategic Merger

PUBLIC · COROct 21, 2026

Acquiring Company

Cencora

Acquired Company

American Oncology Network

ConshohockenDelawareBiotechnologyHealth CarePharmaceuticalBiotechnologyHealth CareMedicalNon Profit

Description

On October 21, 2026, Cencora, Inc. announced its entry into a merger agreement with American Oncology Network, Inc. Through this transaction, Merger Sub will merge with AON, with AON continuing as a wholly-owned subsidiary of Cencora. The merger is expected to enhance the operational capabilities of both companies in the oncology space. Further details surrounding the transaction will be discussed in an upcoming earnings call.

Who to call at Cencora, and when

When Cencora changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Cencora raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cencora, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cencora

Location

Conshohocken, Pennsylvania, United States

About

Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 46,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. Cencora is ranked #11 on the Fortune 500 and #24 on the Global Fortune 500 with more than $250 billion in annual revenue. Learn more at www.investor.cencora.com For further information: Sapphiros, press@sapphiros.com SOURCE Sapphiros

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cencora makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Laurentiu
Senior decision-maker at this company
••••••••@••••••••

See Laurentiu's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Cencora's next move

Learn about Strategic plan

Frequently asked

Who acquired American Oncology Network?

American Oncology Network was acquired by Cencora, based in Conshohocken. The deal was reported on October 21, 2026. Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. Cencora is publicly traded (COR) and operates in Biotechnology.

When did Cencora acquire American Oncology Network?

Cencora's acquisition of American Oncology Network was reported on October 21, 2026. On October 21, 2026, Cencora, Inc. announced its entry into a merger agreement with American Oncology Network, Inc. Through this transaction, Merger Sub will merge with AON, with AON continuing as a wholly-owned subsidiary of Cencora. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does American Oncology Network do?

American Oncology Network, Inc. is a healthcare organization specializing in providing comprehensive oncology services. The company partners with local oncologists to improve care delivery and outcomes for cancer patients. It is privately held, operating in Biotechnology, and is based in Delaware.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.